Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
 Back to Profile

Leigh Perreault

Concepts (332)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Prediabetic State
24
2024
246
6.870
 Why?
Diabetes Mellitus, Type 2
50
2024
2436
5.060
 Why?
Insulin Resistance
32
2024
1165
3.730
 Why?
Hypoglycemic Agents
23
2023
1219
3.250
 Why?
Obesity
29
2024
2880
2.780
 Why?
Blood Glucose
31
2023
2096
2.610
 Why?
Weight Loss
15
2024
733
2.230
 Why?
Muscle, Skeletal
21
2024
1614
2.220
 Why?
Cardiovascular Diseases
15
2020
2001
2.050
 Why?
Insulin
20
2024
2325
1.870
 Why?
Sphingolipids
7
2024
71
1.710
 Why?
Diabetes Mellitus
11
2023
999
1.660
 Why?
Triglycerides
11
2024
527
1.580
 Why?
Benzhydryl Compounds
3
2017
66
1.470
 Why?
Glucose Intolerance
8
2020
142
1.460
 Why?
Diabetic Angiopathies
3
2017
261
1.430
 Why?
Diglycerides
6
2024
61
1.310
 Why?
Diabetes Complications
2
2019
224
1.120
 Why?
Overweight
7
2022
530
1.120
 Why?
Glucosides
2
2017
38
1.090
 Why?
Glucagon-Like Peptide 1
3
2023
112
1.020
 Why?
Life Style
12
2020
460
1.010
 Why?
Metformin
13
2023
315
0.920
 Why?
Primary Health Care
6
2023
1678
0.910
 Why?
Exercise
11
2024
1923
0.890
 Why?
Receptors, Gastrointestinal Hormone
1
2023
6
0.880
 Why?
Anti-Obesity Agents
2
2024
53
0.860
 Why?
Glucose Tolerance Test
15
2021
356
0.850
 Why?
Glucose Clamp Technique
11
2024
194
0.820
 Why?
Goals
2
2021
160
0.800
 Why?
Humans
94
2024
129378
0.770
 Why?
Adult
54
2024
35512
0.770
 Why?
Nutrition Therapy
1
2022
31
0.750
 Why?
Health Equity
1
2023
82
0.750
 Why?
Middle Aged
45
2024
31102
0.750
 Why?
Liver
4
2014
1839
0.720
 Why?
Adipose Tissue
4
2023
590
0.690
 Why?
Hyperglycemia
4
2014
328
0.670
 Why?
Primary Care Nursing
1
2019
4
0.670
 Why?
Male
59
2024
63595
0.640
 Why?
Female
64
2024
68686
0.620
 Why?
Microvessels
1
2019
83
0.610
 Why?
Obesity Management
1
2018
8
0.600
 Why?
Insulin, Long-Acting
1
2019
62
0.600
 Why?
Peripheral Vascular Diseases
1
2019
102
0.600
 Why?
Body Mass Index
12
2024
2270
0.590
 Why?
Infant, Newborn, Diseases
1
2019
110
0.590
 Why?
Glucagon-Like Peptide-1 Receptor
1
2019
92
0.590
 Why?
Awareness
1
2019
99
0.580
 Why?
Fasting
4
2020
267
0.570
 Why?
Precision Medicine
1
2021
387
0.550
 Why?
Ceramides
5
2024
112
0.550
 Why?
Policy
1
2018
144
0.540
 Why?
Risk Factors
19
2023
9752
0.540
 Why?
Weight Reduction Programs
2
2017
111
0.540
 Why?
Risk Management
1
2017
85
0.530
 Why?
Incretins
2
2021
18
0.530
 Why?
Rest
2
2017
120
0.520
 Why?
Choristoma
1
2015
21
0.500
 Why?
Sleep Deprivation
5
2021
171
0.490
 Why?
Insulin-Secreting Cells
2
2010
367
0.460
 Why?
Weight Gain
4
2019
510
0.440
 Why?
Lipid Metabolism
4
2021
497
0.430
 Why?
Lipids
4
2024
625
0.420
 Why?
Sarcolemma
3
2024
40
0.420
 Why?
Randomized Controlled Trials as Topic
4
2022
1360
0.410
 Why?
Glucose
4
2023
1002
0.410
 Why?
Clinical Trials as Topic
1
2017
1004
0.400
 Why?
Phenols
1
2013
97
0.400
 Why?
Physical Endurance
5
2020
262
0.370
 Why?
Glucagon-Like Peptides
2
2022
50
0.360
 Why?
Fenofibrate
1
2011
31
0.360
 Why?
Athletes
7
2024
409
0.350
 Why?
Hypolipidemic Agents
1
2011
92
0.340
 Why?
Cross-Sectional Studies
9
2024
5061
0.340
 Why?
Dipeptidyl-Peptidase IV Inhibitors
1
2010
45
0.330
 Why?
Palmitates
1
2009
17
0.330
 Why?
Phosphatidylcholines
2
2024
146
0.330
 Why?
Aged
17
2023
22052
0.330
 Why?
Hospitalization
1
2019
2070
0.330
 Why?
Pyrazines
1
2010
86
0.320
 Why?
Triazoles
1
2010
152
0.310
 Why?
Sleep
4
2021
683
0.310
 Why?
Energy Metabolism
4
2021
871
0.310
 Why?
Biomarkers
8
2023
3972
0.300
 Why?
Sodium-Glucose Transporter 2
2
2017
22
0.280
 Why?
Risk Reduction Behavior
3
2023
209
0.280
 Why?
Sex Characteristics
3
2021
737
0.270
 Why?
Diabetic Nephropathies
2
2020
284
0.270
 Why?
Double-Blind Method
5
2024
1876
0.270
 Why?
Markov Chains
2
2018
117
0.270
 Why?
Absenteeism
2
2018
47
0.260
 Why?
Sex Factors
5
2018
1966
0.260
 Why?
Health Services
2
2018
99
0.260
 Why?
Adiponectin
3
2018
235
0.250
 Why?
Pilot Projects
2
2021
1587
0.240
 Why?
Renal Insufficiency, Chronic
2
2022
566
0.240
 Why?
Follow-Up Studies
6
2021
4888
0.240
 Why?
Muscle Fibers, Skeletal
3
2024
187
0.240
 Why?
Circadian Rhythm
3
2019
413
0.240
 Why?
Remission Induction
3
2019
272
0.240
 Why?
Young Adult
12
2024
12415
0.230
 Why?
Carnitine
2
2024
76
0.230
 Why?
Dietary Fats
3
2020
301
0.220
 Why?
Lipogenesis
2
2017
59
0.220
 Why?
Lipoprotein Lipase
1
2004
59
0.220
 Why?
Hyperinsulinism
1
2024
119
0.210
 Why?
Oxidation-Reduction
4
2024
1033
0.210
 Why?
Physical Exertion
1
2004
205
0.210
 Why?
Healthy Lifestyle
1
2023
32
0.200
 Why?
Computer Simulation
2
2018
943
0.200
 Why?
Socioeconomic Factors
2
2018
1214
0.200
 Why?
Energy Intake
4
2021
461
0.200
 Why?
Consensus
3
2020
613
0.200
 Why?
Diet, Reducing
3
2017
87
0.200
 Why?
Biopsy
3
2018
1089
0.190
 Why?
Combined Modality Therapy
4
2019
1204
0.190
 Why?
Prevalence
2
2019
2560
0.190
 Why?
Cluster Analysis
1
2023
482
0.190
 Why?
Endpoint Determination
2
2019
76
0.190
 Why?
Dose-Response Relationship, Drug
3
2024
2011
0.180
 Why?
Nephrology
1
2022
60
0.180
 Why?
Glucose Transporter Type 4
1
2021
39
0.180
 Why?
Cytosol
2
2020
218
0.180
 Why?
Ambulatory Care Facilities
1
2023
228
0.180
 Why?
Body Weight
4
2024
940
0.170
 Why?
Risk Adjustment
1
2020
79
0.170
 Why?
Endocrinologists
1
2020
12
0.170
 Why?
New Zealand
1
2019
45
0.170
 Why?
Cytosine
1
2019
46
0.160
 Why?
Pragmatic Clinical Trials as Topic
1
2019
62
0.160
 Why?
Endoplasmic Reticulum
2
2020
261
0.160
 Why?
Fatty Liver
1
2021
231
0.160
 Why?
Liraglutide
1
2019
29
0.150
 Why?
Fatty Acids, Nonesterified
2
2019
160
0.150
 Why?
Exercise Test
3
2015
613
0.150
 Why?
Models, Econometric
1
2018
33
0.150
 Why?
Retinal Diseases
1
2019
86
0.150
 Why?
Adolescent
8
2023
20378
0.150
 Why?
Postprandial Period
1
2019
104
0.150
 Why?
United States
9
2023
13876
0.150
 Why?
Quinolizines
1
1997
8
0.150
 Why?
Colorado
3
2023
4415
0.140
 Why?
Drug Combinations
1
2019
329
0.140
 Why?
Referral and Consultation
1
2023
731
0.140
 Why?
Antiemetics
1
1997
40
0.140
 Why?
Tissue Plasminogen Activator
2
2018
221
0.140
 Why?
Health Resources
1
2018
113
0.140
 Why?
Nausea
1
1997
108
0.140
 Why?
Cholesterol, HDL
2
2015
205
0.140
 Why?
Vomiting
1
1997
126
0.140
 Why?
Hysterectomy
1
1997
118
0.130
 Why?
Severity of Illness Index
2
2018
2737
0.130
 Why?
Odds Ratio
1
2019
1023
0.130
 Why?
Surgical Wound Infection
1
2019
282
0.130
 Why?
Patient-Centered Care
1
2021
504
0.130
 Why?
Patient Participation
1
2019
410
0.130
 Why?
Phosphatidylethanolamines
1
2016
74
0.130
 Why?
Delivery of Health Care
1
2023
893
0.120
 Why?
Phenotype
1
2024
3076
0.120
 Why?
Treatment Outcome
6
2021
10195
0.120
 Why?
Research Design
2
2019
1038
0.120
 Why?
Blotting, Western
2
2016
1205
0.120
 Why?
Eating
2
2021
369
0.120
 Why?
Cost-Benefit Analysis
1
2018
568
0.120
 Why?
Tandem Mass Spectrometry
2
2024
524
0.120
 Why?
Kidney Diseases
1
2019
383
0.120
 Why?
Exercise Therapy
2
2017
412
0.120
 Why?
Patient Compliance
1
2019
564
0.120
 Why?
Costs and Cost Analysis
1
2015
201
0.120
 Why?
Indoles
1
1997
385
0.110
 Why?
Sleep Apnea Syndromes
1
2015
80
0.110
 Why?
Hypoglycemia
1
2019
426
0.110
 Why?
Income
1
2015
189
0.110
 Why?
Somatostatin
1
2014
55
0.110
 Why?
Logistic Models
1
2019
1986
0.110
 Why?
Pneumonia
1
2019
613
0.110
 Why?
Employment
1
2015
167
0.110
 Why?
Health Personnel
1
2019
649
0.110
 Why?
Fructose
1
2014
106
0.110
 Why?
Recovery of Function
2
2015
642
0.110
 Why?
Smoking
2
2012
1501
0.110
 Why?
Cost of Illness
1
2015
278
0.100
 Why?
Metabolic Diseases
1
2014
104
0.100
 Why?
Multicenter Studies as Topic
1
2014
286
0.100
 Why?
Qualitative Research
1
2019
1228
0.100
 Why?
C-Reactive Protein
1
2015
401
0.100
 Why?
Oxygen Consumption
4
2016
672
0.100
 Why?
Fatty Acids, Monounsaturated
1
2012
52
0.100
 Why?
Aged, 80 and over
3
2019
7069
0.100
 Why?
Homeostasis
1
2016
611
0.100
 Why?
Models, Theoretical
1
2016
545
0.100
 Why?
Prospective Studies
3
2019
7111
0.090
 Why?
Adult Children
1
2011
23
0.090
 Why?
Depressive Disorder, Major
1
2015
345
0.090
 Why?
Mitochondria
1
2018
877
0.090
 Why?
Practice Guidelines as Topic
1
2019
1494
0.090
 Why?
Placebos
2
2009
201
0.090
 Why?
Adipocytes
1
2012
205
0.090
 Why?
Age Factors
1
2018
3144
0.090
 Why?
Health Behavior
2
2023
741
0.090
 Why?
Diabetes, Gestational
1
2015
308
0.090
 Why?
Sitagliptin Phosphate
1
2010
31
0.090
 Why?
Comorbidity
1
2015
1546
0.090
 Why?
Family Health
1
2011
197
0.090
 Why?
Health Knowledge, Attitudes, Practice
1
2019
1278
0.090
 Why?
Metabolomics
1
2015
652
0.080
 Why?
Longevity
1
2011
151
0.080
 Why?
Quality of Life
3
2019
2695
0.080
 Why?
Mitochondria, Muscle
2
2021
111
0.080
 Why?
C-Peptide
1
2010
163
0.080
 Why?
Disease Progression
3
2024
2626
0.080
 Why?
Menopause
1
2011
297
0.070
 Why?
Leisure Activities
1
2008
29
0.070
 Why?
Delphi Technique
2
2019
222
0.070
 Why?
Blood Pressure
1
2014
1731
0.070
 Why?
Body Composition
1
2011
649
0.070
 Why?
Risk Assessment
3
2015
3236
0.070
 Why?
Predictive Value of Tests
1
2012
1945
0.070
 Why?
Cohort Studies
4
2021
5414
0.060
 Why?
Fibrinogen
2
2018
164
0.060
 Why?
Postoperative Complications
1
1997
2479
0.060
 Why?
Mass Screening
1
2013
1148
0.060
 Why?
Diabetes Mellitus, Type 1
2
2012
3628
0.060
 Why?
Multivariate Analysis
1
2009
1501
0.060
 Why?
Aging
1
2015
1776
0.060
 Why?
Regression Analysis
2
2019
993
0.060
 Why?
Metabolic Clearance Rate
1
2004
118
0.060
 Why?
Incidence
3
2019
2641
0.060
 Why?
Health Expenditures
1
1986
179
0.060
 Why?
Gene Expression Profiling
2
2023
1706
0.050
 Why?
Prognosis
2
2023
3791
0.050
 Why?
Retrospective Studies
2
2019
14498
0.050
 Why?
Depression
1
2012
1304
0.050
 Why?
Hormones
1
2004
140
0.050
 Why?
Menstrual Cycle
1
2003
121
0.050
 Why?
Mice, Inbred C57BL
1
2013
5438
0.050
 Why?
Parents
1
2011
1308
0.050
 Why?
Alcohol Drinking
1
2009
764
0.050
 Why?
Gastrointestinal Diseases
1
2024
198
0.050
 Why?
Eligibility Determination
1
2023
63
0.050
 Why?
Wakefulness
2
2015
120
0.050
 Why?
Lactic Acid
1
2003
302
0.050
 Why?
Animals
3
2024
35346
0.050
 Why?
Proportional Hazards Models
2
2017
1201
0.050
 Why?
Acute Disease
1
2024
978
0.050
 Why?
Citric Acid Cycle
1
2021
55
0.040
 Why?
Subcellular Fractions
1
2021
81
0.040
 Why?
Injections, Subcutaneous
1
2021
147
0.040
 Why?
Sex Hormone-Binding Globulin
1
2020
53
0.040
 Why?
Motor Activity
2
2015
676
0.040
 Why?
Kinetics
1
2004
1641
0.040
 Why?
Protective Agents
1
2020
39
0.040
 Why?
Education
1
2020
100
0.040
 Why?
Proprotein Convertase 9
1
2020
68
0.040
 Why?
Stearoyl-CoA Desaturase
2
2010
65
0.040
 Why?
Poisson Distribution
1
2019
73
0.040
 Why?
Analysis of Variance
2
2013
1287
0.040
 Why?
Time Factors
3
2019
6550
0.040
 Why?
Stakeholder Participation
1
2019
77
0.040
 Why?
Pregnancy
2
2015
6390
0.040
 Why?
E-Selectin
1
2018
54
0.040
 Why?
Consensus Development Conferences as Topic
1
2018
27
0.040
 Why?
Subcutaneous Fat
1
2019
74
0.040
 Why?
Probability
1
2019
306
0.040
 Why?
Primary Cell Culture
1
2019
160
0.040
 Why?
Chemokine CCL2
1
2018
118
0.040
 Why?
Intercellular Adhesion Molecule-1
1
2018
135
0.040
 Why?
Intra-Abdominal Fat
1
2019
88
0.040
 Why?
Cell Nucleus
1
2020
582
0.040
 Why?
Research
1
2020
416
0.030
 Why?
Leptin
1
2018
219
0.030
 Why?
Diet
3
2012
1212
0.030
 Why?
Case-Control Studies
2
2017
3375
0.030
 Why?
Adaptation, Physiological
2
2010
512
0.030
 Why?
Sequence Analysis, RNA
1
2019
428
0.030
 Why?
Biological Transport
1
2017
401
0.030
 Why?
Metabolome
1
2019
338
0.030
 Why?
Rats
1
2024
5497
0.030
 Why?
Fatty Acids, Unsaturated
1
2016
97
0.030
 Why?
Diet, Fat-Restricted
1
2015
80
0.030
 Why?
Melatonin
1
2015
125
0.030
 Why?
Longitudinal Studies
2
2013
2714
0.030
 Why?
Interleukin-6
1
2018
720
0.030
 Why?
Blood Glucose Self-Monitoring
1
2020
601
0.030
 Why?
Kidney
1
2022
1382
0.030
 Why?
Fatty Acids
1
2016
427
0.030
 Why?
Calorimetry
1
2013
66
0.030
 Why?
Insulin Receptor Substrate Proteins
1
2012
59
0.030
 Why?
Risk
1
2015
854
0.020
 Why?
Glycerol
1
2012
91
0.020
 Why?
Sleep Wake Disorders
1
2015
252
0.020
 Why?
Algorithms
1
2020
1620
0.020
 Why?
RNA, Messenger
2
2010
2707
0.020
 Why?
Calorimetry, Indirect
1
2010
81
0.020
 Why?
Antidepressive Agents
1
2012
228
0.020
 Why?
Genetic Variation
1
2015
937
0.020
 Why?
Surveys and Questionnaires
1
2022
5390
0.020
 Why?
Palmitic Acid
1
2010
40
0.020
 Why?
Nicotine
1
2012
303
0.020
 Why?
Polysomnography
1
2010
162
0.020
 Why?
Retinoid X Receptor gamma
1
2009
4
0.020
 Why?
TOR Serine-Threonine Kinases
1
2012
396
0.020
 Why?
PPAR alpha
1
2009
58
0.020
 Why?
Gene Expression Regulation
1
2019
2548
0.020
 Why?
Bicycling
1
2010
116
0.020
 Why?
Coronary Disease
1
2011
385
0.020
 Why?
Phospholipids
1
2010
215
0.020
 Why?
Women's Health
1
2011
365
0.020
 Why?
Phosphorylation
1
2012
1713
0.020
 Why?
Reference Values
1
2009
793
0.020
 Why?
Mice
1
2024
16935
0.020
 Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2009
958
0.020
 Why?
Genetic Predisposition to Disease
1
2015
2281
0.020
 Why?
Adiposity
1
2012
504
0.020
 Why?
Patient Education as Topic
1
2011
738
0.020
 Why?
Genotype
1
2011
1839
0.020
 Why?
Infant Care
1
1986
46
0.020
 Why?
Infertility
1
1986
51
0.020
 Why?
Health Promotion
1
2011
717
0.010
 Why?
Delivery, Obstetric
1
1986
137
0.010
 Why?
Maternal Health Services
1
1986
95
0.010
 Why?
Contraception
1
1986
153
0.010
 Why?
Follicular Phase
1
2003
38
0.010
 Why?
Anaerobic Threshold
1
2003
28
0.010
 Why?
Spectrophotometry, Ultraviolet
1
2003
84
0.010
 Why?
Abortion, Induced
1
1986
101
0.010
 Why?
Luteal Phase
1
2003
44
0.010
 Why?
Catecholamines
1
2003
96
0.010
 Why?
Polymorphism, Single Nucleotide
1
2011
2071
0.010
 Why?
Heart Rate
1
2003
800
0.010
 Why?
Infant, Newborn
1
1986
5760
0.010
 Why?
Perreault's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (332) concept(s)
_
Co-Authors Expand Description
See all (33) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)